Breitschwerdt Edward B, Maggi Ricardo G, Lantos Paul M, Woods Christopher W, Hegarty Barbara C, Bradley Julie M
Intracellular Pathogens Research Laboratory, Center for Comparative Medicine and Translational Research, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough St,, Raleigh, NC, USA.
Parasit Vectors. 2010 Apr 8;3(1):29. doi: 10.1186/1756-3305-3-29.
Bartonella vinsonii subsp. berkhoffii is an important, emerging, intravascular bacterial pathogen that has been recently isolated from immunocompetent patients with endocarditis, arthritis, neurological disease and vasoproliferative neoplasia. Vector transmission is suspected among dogs and wild canines, which are the primary reservoir hosts. This investigation was initiated to determine if pets and family members were infected with one or more Bartonella species.
PCR and enrichment blood culture in Bartonella alpha Proteobacteria growth medium (BAPGM) was used to determine infection status. Antibody titers to B. vinsonii subsp. berkhoffii genotypes I-III and B. henselae were determined using a previously described indirect fluorescent antibody test. Two patients were tested sequentially for over a year to assess the response to antibiotic treatment.
Intravascular infection with B. vinsonii subsp. berkhoffii genotype II and Bartonella henselae (Houston 1 strain) were confirmed in a veterinarian and his daughter by enrichment blood culture, followed by PCR and DNA sequencing. Symptoms included progressive weight loss, muscle weakness, lack of coordination (the father) and headaches, muscle pain and insomnia (the daughter). B. vinsonii subsp. berkhoffii genotype II was also sequenced from a cerebrospinal fluid BAPGM enrichment culture and from a periodontal swab sample. After repeated courses of antibiotics, post-treatment blood cultures were negative, there was a decremental decrease in antibody titers to non-detectable levels and symptoms resolved in both patients.
B. vinsonii subsp. berkhoffii and B. henselae are zoonotic pathogens that can be isolated from the blood of immunocompetent family members with arthralgias, fatigue and neurological symptoms. Therapeutic elimination of Bartonella spp. infections can be challenging, and follow-up testing is recommended. An increasing number of arthropod vectors, including biting flies, fleas, keds, lice, sandflies and ticks have been confirmed or are suspected as the primary mode of transmission of Bartonella species among animal populations and may also pose a risk to human beings.
文森巴尔通体伯克霍夫亚种是一种重要的、新出现的血管内细菌病原体,最近已从患有心内膜炎、关节炎、神经系统疾病和血管增生性肿瘤的免疫功能正常患者中分离出来。狗和野生犬科动物是主要的储存宿主,怀疑存在媒介传播。开展这项调查是为了确定宠物和家庭成员是否感染了一种或多种巴尔通体菌种。
采用聚合酶链反应(PCR)和在巴尔通体α变形菌生长培养基(BAPGM)中进行富集血培养来确定感染状况。使用先前描述的间接荧光抗体试验测定针对文森巴尔通体伯克霍夫亚种I - III基因型和亨氏巴尔通体的抗体滴度。对两名患者进行了为期一年多的连续检测,以评估对抗生素治疗的反应。
通过富集血培养,随后进行PCR和DNA测序,在一名兽医及其女儿体内确诊了文森巴尔通体伯克霍夫亚种II基因型和亨氏巴尔通体(休斯顿1菌株)的血管内感染。症状包括进行性体重减轻、肌肉无力、协调能力缺乏(父亲)以及头痛、肌肉疼痛和失眠(女儿)。文森巴尔通体伯克霍夫亚种II基因型也从脑脊液BAPGM富集培养物和牙周拭子样本中测序得到。在反复使用抗生素疗程后,治疗后血培养结果为阴性,抗体滴度逐渐降低至不可检测水平,两名患者的症状均得到缓解。
文森巴尔通体伯克霍夫亚种和亨氏巴尔通体是人畜共患病原体,可从有关节痛、疲劳和神经系统症状的免疫功能正常家庭成员的血液中分离出来。治疗消除巴尔通体菌种感染可能具有挑战性,建议进行随访检测。越来越多的节肢动物媒介,包括叮咬蝇、跳蚤、蜱蝇、虱子、白蛉和蜱虫,已被证实或被怀疑是动物群体中巴尔通体菌种的主要传播方式,也可能对人类构成风险。